(Q40620300)

English

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization

scientific article published on June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Vela-Ojeda J

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Tripp-Villanueva F

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Montiel-Cervantes L

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sánchez-Cortés E

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ayala-Sánchez M

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Guevara-Moreno ME

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

García-León LD

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Rosas-Cabral A

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Esparza MA

9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

González-Llaven J

10

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1141-1146

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702426

0 references

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Ifosfamide encephalopathy: a reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

21 January 2018

Clinical pharmacology of isophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

7 January 2021

based on heuristic

inferred from DOI database lookup

31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702426

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702426

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40620300&oldid=1903745841"